Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Orthofix Sees Prelim. Q3 Net Sales $114M

Author: Bill Haddad | October 11, 2022 06:09am

Third quarter net sales of $114 million, an increase of 1% on a reported basis and 5% on a constant currency basis over prior year
Global Orthopedics net sales growth of 19% on a constant currency basis driven by commercial channel investments
Biologics net sales growth of 8% driven by new product introductions
Bone Growth Therapies net sales growth of 3% driven by the commercial roll-out of AccelStim™ Bone Healing Therapy
Announced agreement to merge with SeaSpine Holdings Corporation (NASDAQ:SPNE, SeaSpine", , ))))), creating a leading global spine and orthopedics company

Posted In: OFIX SPNE